If you notice any of these side effects, contact a doctor immediately or go to the nearest emergency service.
Very common side effects(these side effects can affect more than 1 in 10 patients)
Common side effects(these side effects can affect up to 1 in 10 patients)
Rare side effects(these side effects can affect up to 1 in 100 patients)
Very rare side effects(these side effects can affect up to 1 in 1,000 patients)
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use website: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
.
Famciclovir Teva Composition
The active ingredient is famciclovir. A tablet contains 250 mg of famciclovir.
The other components are microcrystalline cellulose E460, sodium glycolate starch (Type A) from potato, anhydrous colloidal silica E551, low-substitution hydroxypropyl cellulose, sodium croscarmellose, sodium stearate fumarate, titanium dioxide E 171, dextrin, hypromellose, triacetin, and macrogol.
Product Appearance and Packaging Contents
Film-coated tablets, white to off-white in color, round, engraved with 8118 on one face and 93 on the other face.
They are presented in packaging of: 1, 10, 14, 15, 20, 21, 30, 56, and 60 film-coated tablets.
Only some packaging sizes may be commercially available.
Marketing Authorization Holder and Responsible Manufacturer
Marketing Authorization Holder:
Teva Pharma S.L.U.
C/ Anabel Segura, 11,
Edificio Albatros B, 1st floor
Alcobendas (Madrid)
Spain
Responsible Manufacturer:
Pharmachemie B.V.
Swensweg 5, Haarlem, 2031 GAHolland
Or
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
Or
Merckle GmbH,
Graf-Arco-Str. 3,Ulm, 89079,
Germany
This medication is authorized in the member states of the European Economic Area with the following names:
Slovakia | Famciclovir – Teva 250 mg |
Spain | Famciclovir TEVA 250 mg film-coated tablets EFG |
Ireland | Famciclovir Teva 250 mg Film-coated Tablets |
Italy | Famciclovir Teva |
This leaflet was approved in June 2015
Detailed information about this medication is available on the website of the {Spanish Agency of Medicines and Medical Devices (AEMPS)} (http://www.aemps.gob.es/)
You can access detailed and updated information about this medication by scanning the QR code included in the carton with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/69341/P_69341.html
QR code + URL
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.